I sat with her while she searched, and honestly, the numbers we found were more complicated — and in some ways more reassuring — than either of us expected. Brain tumors are not as rare as people assume. They’re also not as universally deadly as the word “tumor” makes them sound. The full picture depends heavily on what type you’re talking about.

Her mass turned out to be a small, benign finding that needed nothing more than monitoring. But the research we did that night stuck with me, so I went back and put together the actual data in a way that makes sense — because I think a lot of people search this exact question in moments of fear, and they deserve real numbers, not vague reassurance.

The Headline Numbers for the United States

Let’s start with the big picture. In 2026, the American Cancer Society estimates that around 24,740 new malignant brain and spinal cord tumors will be diagnosed in the US, split roughly between 13,830 men and 10,910 women. Alongside that, an estimated 18,350 people are expected to die from these cancers this year.

That sounds heavy on its own, but here’s important context: malignant brain and spinal cord cancers make up only about 1% of all new cancer diagnoses in the United States each year. The lifetime risk of developing a malignant brain or spinal cord tumor is actually less than 1% for the average person.

But that statistic only covers malignant (cancerous) tumors. It leaves out an enormous category — non-malignant, or benign, brain tumors — which are actually far more common than the cancerous kind.

The Bigger Picture: Malignant Plus Non-Malignant Combined

This is where the numbers get more interesting, and honestly, where most people’s understanding is incomplete.

According to the Central Brain Tumor Registry of the United States (CBTRUS), which tracks both malignant and non-malignant brain and CNS tumors, the overall average annual incidence rate between 2018 and 2022 was about 26 cases per 100,000 people. That translates into roughly 107,100 new brain or CNS tumor diagnoses expected across the country this year alone.

Out of that total, malignant tumors account for about 6.86 cases per 100,000 people, while non-malignant tumors account for a much larger share — around 19.19 cases per 100,000. In plain terms, benign brain tumors are diagnosed roughly three times more often than malignant ones.

This matters because when most people hear “brain tumor,” they immediately picture the worst-case scenario. In reality, the majority of brain tumors diagnosed each year are not cancerous, don’t spread, and often have a much more manageable treatment path.

Why Women Are Diagnosed More Often — But Men Face Higher Malignant Rates

One of the more surprising patterns in the data is the gender split.

Overall, women have a higher total incidence rate of brain tumors than men — around 29.67 per 100,000 for women compared to about 22.23 per 100,000 for men. At first glance, that looks like women are simply more at risk.

But when you separate out malignant tumors specifically, the pattern flips. Men actually have a slightly higher rate of malignant brain tumors than women. The overall female lead comes almost entirely from one specific tumor type: meningiomas, which occur far more frequently in women, particularly during and after their reproductive years.

Meningiomas are typically non-malignant and grow on the membranes surrounding the brain rather than in brain tissue itself. They’re so common in women that they essentially pull the overall numbers upward, even though women are not more likely to face the more dangerous, malignant forms of brain tumors.

The Most Common Types You’ll Actually Encounter

If you’re trying to understand brain tumor statistics, it helps to know which specific types are actually driving these numbers.

Meningiomas are the single most common brain tumor type overall, accounting for roughly 42% of all primary brain tumors diagnosed and well over half of all non-malignant tumors. Most are slow-growing and many never cause serious problems.

Glioblastoma sits at the opposite end of the spectrum. It’s the most common malignant brain tumor in adults, making up around 14% of all primary brain tumors but over half of all malignant ones. It’s also one of the most aggressive cancers that exists, which is why it gets so much attention despite being a relatively small slice of the overall brain tumor population.

Between these two extremes sit dozens of other tumor types — pituitary tumors, acoustic neuromas, various forms of glioma — each with their own typical behavior, growth pattern, and treatment approach.

Age Changes Everything About These Numbers

Brain tumor statistics shift dramatically depending on which age group you’re looking at.

In children ages 0 to 14, brain and other nervous system tumors are the most commonly diagnosed solid cancer and sadly remain the leading cause of childhood cancer death. An estimated 3,366 new childhood primary brain tumor cases are expected in the US this year.

Among adolescents and young adults, ages 15 to 39, brain tumors are the second most common cancer type overall and the second leading cause of cancer-related death in that age range, with roughly 13,474 new cases projected this year.

For adults over 40, the numbers grow substantially larger — an estimated 81,104 new primary brain tumor diagnoses are expected in this age group alone this year, making brain tumors the seventh most common tumor type among adults. The median age at diagnosis for a primary brain tumor overall sits at around 62 years old.

So while brain tumors absolutely happen at every age — and devastatingly so in children — the overall numbers climb steadily as people get older, which is true of most cancers.

What Survival Statistics Actually Tell You

Survival rates are probably the number people search for most anxiously, and they vary enormously depending on tumor type.

Looking at all primary brain tumors combined — malignant and non-malignant together — the overall five-year relative survival rate is around 75.8%. But that combined number hides a massive split underneath it.

Patients with non-malignant brain tumors have a five-year survival rate often cited above 90%, since most benign tumors respond well to surgery or can simply be monitored without major intervention. Patients with malignant brain tumors face a much steeper road, with five-year survival rates in some analyses sitting around 35%, dragged down significantly by aggressive types like glioblastoma, where five-year survival is far lower still.

This is exactly why “brain tumor survival rate” is such a misleading search term on its own. The honest answer always depends entirely on which specific tumor type, grade, and location you’re asking about.

How the US Compares Globally

If you zoom out to a worldwide view, the picture looks a bit different. Global data tracked through the International Agency for Research on Cancer puts the worldwide age-adjusted incidence rate of malignant primary brain and CNS tumors at around 3.5 cases per 100,000 people, translating to roughly 321,000 new cases globally in a recent year.

Incidence rates vary significantly by country, largely influenced by access to diagnostic imaging. Countries with widespread MRI access tend to report higher numbers simply because more tumors get caught and recorded, while countries with less healthcare infrastructure likely have significant underdiagnosis rather than genuinely lower rates.

What These Numbers Actually Mean If You’re Worried

If you’re reading this because you or someone you love just received a concerning scan result, here’s what I’d want you to take from all these statistics.

Brain tumors are common enough that you are far from alone — over a hundred thousand people in the US receive some form of brain tumor diagnosis every year. Most of those diagnoses are non-malignant, and many come with genuinely good outcomes.

The specific type of tumor matters infinitely more than the general category of “brain tumor.” A meningioma and a glioblastoma share a location, not much else. Ask your medical team specifically what type and grade you or your loved one is dealing with before letting general statistics — good or bad — shape your expectations.

And remember that statistics describe populations, not individuals. Survival rates are calculated across thousands of people with widely varying ages, overall health, treatment access, and tumor characteristics. Your specific situation, with your specific medical team, is its own story — not just a data point on a chart.

A Final Word

My friend’s “mass” turned out to be nothing dangerous, but that night of searching statistics together taught me something important: numbers without context create more fear than they resolve.

Brain tumors are common. Brain cancer specifically is much less common than the broader category suggests. And within both groups, outcomes vary so widely that no single statistic can tell you what your own story is going to look like.

If you’ve found yourself here searching these numbers at midnight like she did, I hope this gave you something more useful than panic — actual context to bring into your next conversation with a doctor who knows your specific situation far better than any statistic ever could.

Disclaimer: This article is written for educational and informational purposes only and does not constitute medical advice. Statistics are based on the most recently published data from the American Cancer Society, CBTRUS, the National Brain Tumor Society, and SEER at the time of writing, and are subject to annual revision. Please consult a qualified healthcare professional for guidance specific to any individual diagnosis.

Sources

• American Cancer Society — Cancer Facts & Figures 2026
• CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States, 2018–2022
• National Brain Tumor Society — Brain Tumor Facts
• National Cancer Institute, SEER Cancer Stat Facts: Brain and Other Nervous System Cancer
• International Agency for Research on Cancer / GLOBOCAN 2022